UAE Central Nervous System Therapeutic Market Size & Outlook

The central nervous system therapeutic market in the UAE is expected to reach a projected revenue of US$ 575.3 million by 2028. A compound annual growth rate of 6.1% is expected of the UAE central nervous system therapeutic market from 2021 to 2028.
Revenue, 2020 (US$M)
$357.1
Forecast, 2028 (US$M)
$575.3
CAGR, 2021 - 2028
6.1%
Report Coverage
UAE

UAE central nervous system therapeutic market, 2018-2028 (US$M)

UAE

UAE central nervous system therapeutic market highlights

  • The UAE central nervous system therapeutic market generated a revenue of USD 357.1 million in 2020 and is expected to reach USD 575.3 million by 2028.
  • The UAE market is expected to grow at a CAGR of 6.1% from 2021 to 2028.
  • In terms of segment, mental health was the largest revenue generating disease in 2020.
  • CNS Cancer is the most lucrative disease segment registering the fastest growth during the forecast period.


Central nervous system therapeutic market data book summary

Market revenue in 2020USD 357.1 million
Market revenue in 2028USD 575.3 million
Growth rate6.1% (CAGR from 2020 to 2028)
Largest segmentMental health
Fastest growing segmentCNS Cancer
Historical data2018 - 2019
Base year2020
Forecast period2021 - 2028
Quantitative unitsRevenue in USD million
Market segmentationNeurovascular Diseases, CNS Trauma, Mental Health, Neurodegenerative Diseases, Infectious Diseases, CNS Cancer
Key market players worldwideBiogen Inc, Otsuka Pharmaceutical, Eli Lilly and Co, Merck & Co Inc, AstraZeneca PLC, Novartis AG ADR, Teva Pharmaceutical Industries Ltd, Johnson & Johnson, Pfizer Inc


Other key industry trends

  • In terms of revenue, UAE accounted for 0.3% of the global central nervous system therapeutic market in 2020.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
  • In Middle East & Africa, Saudi Arabia central nervous system therapeutic market is projected to lead the regional market in terms of revenue in 2028.
  • South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 924.1 million by 2028.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Central Nervous System Therapeutic Market Companies

Name Profile # Employees HQ Website

UAE central nervous system therapeutic market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to central nervous system therapeutic market will help companies and investors design strategic landscapes.


Mental health was the largest segment with a revenue share of 51.67% in 2020. Horizon Databook has segmented the UAE central nervous system therapeutic market based on neurovascular diseases, cns trauma, mental health, neurodegenerative diseases, infectious diseases, cns cancer covering the revenue growth of each sub-segment from 2018 to 2028.


Studies from the WHO indicate that depression and anxiety are the two most common (~75 %) psychological conditions in UAE, affecting approximately 4% to 5% of the population and is among the top 10 causes of illness & death. 

Mental health is classified as a vital component of UAE’s healthcare system. Furthermore, the country aims to reduce the deaths related to noncommunicable diseases such as mental disorder to one-third by 2030 by offering higher standards of services.

 thereby promoting mental health and wellbeing. The current prevalence of neurodegenerative diseases is low due to a relatively young population. However, the proportion of people in the same age group is expected to increase to 30% by 2050.

Reasons to subscribe to UAE central nervous system therapeutic market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of UAE central nervous system therapeutic market databook

  • Our clientele includes a mix of central nervous system therapeutic market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the UAE central nervous system therapeutic market , including forecasts for subscribers. This country databook contains high-level insights into UAE central nervous system therapeutic market from 2018 to 2028, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

UAE central nervous system therapeutic market size, by disease, 2018-2028 (US$M)

UAE Central Nervous System Therapeutic Market Outlook Share, 2020 & 2028 (US$M)

UAE central nervous system therapeutic market size, by disease, 2018-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more